Mechanistic explanation of structural and functional changes induced by methionine mutation in G-CSF protein

Aritomi, 1999, Atomic structure of the GCSF-receptor complex showing a new cytokine-receptor recognition scheme, Nature, 401, 713, 10.1038/44394 Baldwin, 1996, Thermodynamic and structural compensation in “size-switch” core repacking variants of bacteriophage T4 lysozyme, J. Mol. Biol., 259, 542, 10.1006/jmbi.1996.0338 Chaiken, 1996, Identifying structure-function relationships in four-helix bundle cytokines: towards de novo mimetics design, Trends Biotechnol., 14, 369, 10.1016/0167-7799(96)10050-0 Chang, 1999, Repressor-AFLR interaction modulates aflatoxin biosynthesis in Aspergillus parasiticus, Mycopathologia, 147, 105, 10.1023/A:1007157309168 Daura, 1998, Reversible peptide folding in solution by molecular dynamics simulation, J. Mol. Biol., 280, 925, 10.1006/jmbi.1998.1885 Dominguez, 2003, HADDOCK: a protein-protein docking approach based on biochemical or biophysical information, J. Am. Chem. Soc., 125, 1731, 10.1021/ja026939x Eon-Duval, 2012, Quality attributes of recombinant therapeutic proteins: an assessment of impact on safety and efficacy as part of a quality by design development approach, Biotechnol. Prog., 28, 608, 10.1002/btpr.1548 Guex, 1997, SWISS-MODEL and the Swiss-PdbViewer: an environment for comparative protein modeling, Electrophoresis, 18, 2714, 10.1002/elps.1150181505 Heikoop, 1997, Structure-based design and protein engineering of intersubunit disulfide bonds in gonadotropins, Nat. Biotechnol., 15, 658, 10.1038/nbt0797-658 Hess, 2008, GROMACS4: algorithms for highly efficient, load-balanced, and scalable molecular simulation, J. Chem. Theory Comput., 4, 435, 10.1021/ct700301q Humphrey, 1996, VMD: visual molecular dynamics, J. Mol. Graph., 14, 33, 10.1016/0263-7855(96)00018-5 Ishikawa, 1992, The substitution of cysteine 17 of recombinant human G-CSF with alanine greatly enhanced its stability, Cell Struct. Funct., 17, 61, 10.1247/csf.17.61 Ji, 1998, G protein-coupled receptors. I. Diversity of receptor-ligand interactions, J. Biol. Chem., 273, 17299, 10.1074/jbc.273.28.17299 Jiang, 2011, Effect of a structurally modified human granulocyte colony stimulating factor, G-CSFa, on leukopenia in mice and monkeys, J. Hematol. Oncol., 4, 28, 10.1186/1756-8722-4-28 Kolvenbach, 1997, Granulocyte-colony stimulating factor maintains a thermally stable, compact, partially folded structure at pH 2, J. Pept. Res., 50, 310, 10.1111/j.1399-3011.1997.tb01472.x Kumari, 2014, g_mmpbsa—a GROMACS tool for high-throughput MM-PBSA calculations, J. Chem. Inf. Model., 54, 1951, 10.1021/ci500020m Laskowski, 2011, LigPlot+: multiple ligand-protein interaction diagrams for drug discovery, J. Chem. Inf. Model., 51, 2778, 10.1021/ci200227u Lowman, 1993, Affinity maturation of human growth hormone by monovalent phage display, J. Mol. Biol., 234, 564, 10.1006/jmbi.1993.1612 Lu, 1999, Chemical modification and site-directed mutagenesis of methionine residues in recombinant human granulocyte colony-stimulating factor: effect on stability and biological activity, Arch. Biochem. Biophys., 362, 1, 10.1006/abbi.1998.1022 MacKerell, 1998, All-atom empirical potential for molecular modeling and dynamics studies of proteins, J. Phys. Chem. B, 102, 3586, 10.1021/jp973084f Maiorov, 1994, Significance of root-mean-square deviation in comparing three-dimensional structures of globular proteins, J. Mol. Biol., 235, 625, 10.1006/jmbi.1994.1017 Mehta, 2015, G-CSF and GM-CSF in neutropenia, J. Immunol., 195, 1341, 10.4049/jimmunol.1500861 Mott, 1995, Four-helix bundle growth factors and their receptors: protein-protein interactions, Curr. Opin. Struct. Biol., 5, 114, 10.1016/0959-440X(95)80016-T Murray, 2000, Growth hormone: current and future therapeutic applications, Expert. Opin. Pharmacother., 1, 975, 10.1517/14656566.1.5.975 Okabe, 1990, In vitro and in vivo hematopoietic effect of mutant human granulocyte colony-stimulating factor, Blood, 75, 1788, 10.1182/blood.V75.9.1788.bloodjournal7591788 Park, 2015, Site-specifically modified recombinant human granulocyte colony-stimulating factor with polyethylene glycol, Biotechnology, 14, 200, 10.3923/biotech.2015.200.205 Russel, 1982, A simple method for displaying the hydropathic character of a protein, J. Mol. Biol., 157, 105, 10.1016/0022-2836(82)90515-0 Sarkar, 2002, Rational cytokine design for increased lifetime and enhanced potency using pH-activated “histidine switching”, Nat. Biotechnol., 20, 908, 10.1038/nbt725 Singh, 2017, Determination of critical quality attributes for a biotherapeutic in the QbD paradigm: GCSF as a case study, AAPS J., 19, 1826, 10.1208/s12248-017-0139-8 Tan, 1998, Contributions of a highly conserved VH/VL hydrogen bonding interaction to scFv folding stability and refolding efficiency, Biophys. J., 75, 1473, 10.1016/S0006-3495(98)74066-4 Uchiyama, 2016, Biophysical characterization of biopharmaceuticals, including antibody drugs, Yakugaku Zasshi, 136, 443, 10.1248/yakushi.15-00236-2 Wells, 1996, Hematopoietic receptor complexes, Annu. Rev. Biochem., 65, 609, 10.1146/annurev.bi.65.070196.003141 Zink, 1994, Structure and dynamics of the human granulocyte colony-stimulating factor determined by NMR spectroscopy. Loop mobility in a four-helix-bundle protein, Biochemistry, 33, 8453, 10.1021/bi00194a009